Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

Journal of Experimental Medicine

Volumn 206, Issue 2, 2009, Pages 299-311

  Conti, Heather R ^a   Shen, Fang ^a   Nayyar, Namrata ^a   Stocum, Eileen ^a   Sun, Jianing N ^a   Lindemann, Matthew J ^a   Ho, Allen W ^a   Hai, Justine Hoda ^a   Yu, Jeffrey J ^b   Jung, Ji Won ^a   Filler, Scott G ^c   Masso Welch, Patricia ^a   Edgerton, Mira ^a   Gaffen, Sarah L ^a,b,d  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA DEFENSIN 3; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 23; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 23P19; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL LINEAGE; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION PROFILING; HOST RESISTANCE; MOUSE; MOUTH MUCOSA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SALIVA ANALYSIS; SIGNAL TRANSDUCTION; TH17 CELL; THRUSH; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; CD4+ T LYMPHOCYTE; DISEASE PREDISPOSITION; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOLOGY; MOUSE MUTANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CANDIDIASIS, ORAL; CD4-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 63049138176     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20081463     Document Type: Article

References (77)

1. Klein, R.S., C.A. Harris, C.B. Small, B. Moll, M. Lesser, and G.H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311:354-358.
2. Dongari-Bagtzoglou, A., and P. Fidel. 2005. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J. Dent. Res. 84:966-977.
3. Scully, C., M. el-Kabir, and L.P. Samaranayake. 1994. Candida and oral candidosis: a review. Crit. Rev. Oral Biol. Med. 5:125-157.
4. Fidel, P.L., and J.D. Sobel. 1998. Protective immunity in experimental Candida vaginitis. Res. Immunol. 149:361-373.
5. Ghilardi, N., and W. Ouyang. 2007. Targeting the development and effector functions of Th17 cells. Semin. Immunol. 19:383-393.
6. Trinchieri, G., S. Pflanz, and R.A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 19:641-644.
7. Fantini, M.C., G. Monteleone, and T.T. Macdonald. 2007. New players in the cytokine orchestra of inflammatory bowel disease. Inflamm. Bowel Dis. 13:1419-1423.
8. Aujla, S.J., P.J. Dubin, and J. K. Kolls. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19:377-382.
9. Raffatellu, M., R.L. Santos, D.E. Verhoeven, M.D. George, R.P. Wilson, S.E. Winter, I. Godinez, S. Sankaran, T.A. Paixao, M.A. Gordon, et al. 2008. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14:421-428.
10. Shen, F., and S.L. Gaffen. 2008. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine. 41:92-104.
11. Acosta-Rodriguez, E.V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8:639-646.
12. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204:1849-1861.
13. Hirota, K., H. Yoshitomi, M. Hashimoto, S. Maeda, S. Teradaira, N. Sugimoto, T. Yamaguchi, T. Nomura, H. I to, T. Nakamura, et al.
14. 2007. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204:2803-2812.
15. de Repentigny, L., D. Lewandowski, and P. Joliceur. 2004. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 17:729-759.
16. Yu, J. J., M. Ruddy, G. Wong, C. Sfintescu, P. Baker, J. Smith, R. Evans, and S. Gaffen. 2007. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood. 109:3794-3802.
17. Yu, J.J., M. Ruddy, H. Conti, K. Boonanantanasarn, and S.L. Gaffen. 2008. The IL-17 receptor plays a gender-dependent role in host protection against P. gingivalis-induced periodontal bone loss. Infect. Immun. 76:4206-4213.
18. Huang, W., L. Na, P.L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
19. Leibundgut-Landmann, S., O. Gross, M.J. Robinson, F. Osorio, E.C. Slack, S.V. Tsoni, E. Schweighoffer, V. Tybulewicz, G.D. Brown, J. Ruland, and E.S.C. Reis. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce in- terleukin 17. Nat. Immunol. 8:630-638.
20. Taylor, P.R., S.V. Tsoni, J.A. Willment, K.M. Dennehy, M. Rosas, H. Findon, K. Haynes, C. Steele, M. Botto, S. Gordon, and G.D. Brown. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8:31-38.
21. Milner, J. D., J. M. Brenchley, A. Laurence, A.F. Freeman, B.J. Hill, K.M. Elias, Y. Kanno, C. Spalding, H.Z. Elloumi, M.L. Paulson, et al. 2008. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 452:773-776.
22. Rudner, X.L., K. Happel, E. Young, and J. Shellito. 2007. Interleukin- 12 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun. 75:3055-3061.
23. Zelante, T., A. De Luca, P. Bonifazi, C. Montagnoli, S. Bozza, S. Moretti, M.L. Belladonna, C. Vacca, C. Conte, P. Mosci, et al. 2007.
24. IL-23 and the Th17 pathway promote inflammation and impair antifun- gal immune resistance. Eur. J. Immunol. 37:2695-2706.
25. Kolls, J.K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity. 21:467-476.
26. Farah, C.S., Y. Hu, S. Riminton, and R. Ashman. 2006. Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candi- diasis defined by gene targeting. Oral Microbiol. Immunol. 21:252-255.
27. Kamai, Y., M. Kubota, Y. Kamai, T. Hosokawa, T. Fukuoka, and S. Filler. 2001. New model of oropharyngeal candidiasis in mice. Antimicrob. Agents Chemo. 45:3195-3197.
28. Stumhofer, J.S., A. Laurence, E.H. Wilson, E. Huang, C.M. Tato, L.M. Johnson, A.V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17- producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937-945.
29. Aujla, S.J., Y.R. Chan, M. Zheng, M. Fei, D.J. Askew, D.A. Pociask, T.A. Reinhart, F. McAllister, J. Edeal, K. Gaus, et al. 2008. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-281.
30. Zheng, Y., P.A. Valdez, D.M. Danilenko, Y. Hu, S.M. Sa, Q. Gong, A.R. Abbas, Z. Modrusan, N. Ghilardi, F.J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-289.
31. Stark, M.A., Y. Huo, T.L. Burcin, M.A. Morris, T.S. Olson, and K. Ley. 2005. Phagocytosis of apoptotic neutrophils regulates granulopoi- esis via IL-23 and IL-17. Immunity. 22:285-294.
32. Lockhart, E., A.M. Green, and J. Flynn. 2006. I L-17 production by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177:4662-4669.
33. Shibata, K., H. Yamada, H. Hara, K. Kishihara, and Y. Yoshikai. 2007. Resident Vdelta1+ gammadelta T cells control early infiltration of neu- trophils after Escherichia coli infection via IL-17 production. J. Immunol. 178:4466-4472.
34. Rachitskaya, A.V., A.M. Hansen, R. Horai, Z. Li, R. Villasmil, D. Luger, R.B. Nussenblatt, and R.R. Caspi. 2008. Cutting edge: NKT cells constitutively express IL-23 receptor and ROR{gamma}t and rapidly produce IL-17 upon receptor Ligation in an IL-6-independent fashion. J. Immunol. 180:5167-5171.
35. Liu, X.K., J.L. Clements, and S.L. Gaffen. 2005. Signaling through the murine T cell receptor induces IL-17 production in the absence of co-stimulation, IL-23 or dendritic cells. Mol. Cells. 20:329-337.
36. Gaffen, S. 2008. An overview of IL-17 receptor function and signaling. Cytokine. 42:403-407.
37. Willment, J.A., and G.D. Brown. 2008. C-type lectin receptors in anti- fungal immunity. Trends Microbiol. 16:27-32.
38. Wells, C.A., J.A. Salvage-Jones, X. Li, K. Hitchens, S. Butcher, R.Z. Murray, A.G. Beckhouse, Y.L. Lo, S. Manzanero, C. Cobbold, et al. 2008. The macrophage-inducible C-Type lectin, Mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 180:7404-7413.
39. Vylkova, S., X.S. Li, J.C. Berner, and M. Edgerton. 2006. Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides. Antimicrob. Agents Chemother. 50:324-331.
40. Yang, D., Q. Chen, D. Hoover, P. Staley, K. Tucker, J. Lubkowski, and J. Oppenheim. 2003. Many chemokines including CCL20/MIP- 3alpha display antimicrobial activity. J. Leukoc. Biol. 74:448-455.
41. Leung, K.C., A.S. McMillan, B.P. Cheung, and W.K. Leung. 2008. Sjogren's syndrome sufferers have increased oral yeast levels despite regular dental care. Oral Dis. 14:163-173.
42. Almstahl, A., U. Kroneld, A. Tarkowski, and M. Wikstrom. 1999. Oral microbial flora in Sjogren's syndrome. J. Rheumatol. 26:110-114.
43. Edgerton, M., S.E. Koshlukova, M.W. Araujo, R.C. Patel, J. Dong, and J.A. Bruenn. 2000. Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob. Agents Chemother. 44:3310-3316.
44. Odds, F.C. 1998. Pathogenesis of candidosis. In Candida and Candidosis. F.C. Odds, editor Bailliere Tindall, 252-278.
45. Raman, T., and P. Marik. 2006. Fungal infections in bone marrow transplant recipients. Expert Opin. Pharmacother. 7:307-315.
46. Weindl, G., J. R. Naglik, S. Kaesler, T. Biedermann, B. Hube, H.C. Korting, and M. Schaller. 2007. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J. Clin. Invest. 117:3664-3672.
47. Saijo, S., N. Fujikado, T. Furuta, S.H. Chung, H. Kotaki, K. Seki, K. Sudo, S. Akira, Y. Adachi, N. Ohno, et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albi- cans. Nat. Immunol. 8:39-46.
48. Bozza, S., T. Zelante, S. Moretti, P. Bonifazi, A. DeLuca, C. D'Angelo, G. Giovannini, C. Garlanda, L. Boon, F. Bistoni, et al. 2008. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J. Immunol. 180:4022-4031.
49. Yu, J. J., and S.L. Gaffen. 2008. I nterleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity. Front. Biosci. 13:170-177.
50. Linden, A., M. Laan, and G. Anderson. 2005. Neutrophils, interleukin- 17A and lung disease. Eur. Respir. J. 25:159-172.
51. O'Shea, J.J., A. Ma, and P. Lipsky. 2002. Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37-45.
52. Kramer, J., and S. Gaffen. 2007. I nterleukin-17: A new paradigm in inflammation, autoimmunity and therapy. J. Periodontol. 78:1083-1093.
53. Pepin, L.F., T. Roger, J. Morisset, and M. Seman. 1993. Preferential V delta 1 expression among TcR gamma/delta-bearing T cells in human oral epithelium. Scand. J. Immunol. 37:289-294.
54. Wormley, F.L. Jr., C. Steele, K. Wozniak, K. Fujihashi, J.R. McGhee, and P.L. Fidel Jr. 2001. Resistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis. Infect. Immun. 69:7162-7164.
55. Jones-Carson, J., A. Vazquez-Torres, H.C. van der Heyde, T. Warner, R.D. Wagner, and E. Balish. 1995. Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat. Med. 1:552-557.
56. Mathews, M., H.P. Jia, J. M. Guthmiller, G. Losh, S. Graham, G.K. Johnson, B.F. Tack, and P.B. McCray J r. 1999. Production of beta- defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect. Immun. 67:2740-2745.
57. Feng, Z., B. Jiang, J. Chandra, M. Ghannoum, S. Nelson, and A. Weinberg. 2005. Human beta-defensins: differential activity against candi- dal species and regulation by Candida albicans. J. Dent. Res. 84:445-450.
58. Kao, C.Y., Y. Chen, P. Thai, S. Wachi, F. Huang, C. Kim, R.W. Harper, and R. Wu. 2004. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J. Immunol. 173:3482-3491.
59. Yang, D., O. Chertov, S.N. Bykovskaia, Q. Chen, M.J. Buffo, J. Shogan, M. Anderson, J.M. Schroder, J.M. Wang, O.M.Z. Howard, and J.J. Oppenheim. 1999. |3-Defensins: linking innate immunity and adaptive immunity through dendritic and T cell CCR6. Science. 286:525-528.
60. Raquil, M.A., N. Anceriz, P. Rouleau, and P.A. Tessier. 2008. Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in Streptococcal pneumonia. J. Immunol. 180:3366-3374.
61. Kao, C.-Y., F. Huang, Y. Chen, P. Thai, S. Wachi, C. Kim, L. Tam, and R. Wu. 2005. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK-NF-kappaB-dependent signaling pathway. J. Immunol. 175:6676-6685.
62. Zrioual, S., M.L. Toh, A. Tournadre, Y. Zhou, M.A. Cazalis, A. Pachot, V. Miossec, and P. Miossec. 2008. IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J. Immunol. 180:655-663.
63. Wilson, N.J., K. Boniface, J.R. Chan, B.S. McKenzie, W.M. Blumenschein, J.D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human in- terleukin 17-producing helper T cells. Nat. Immunol. 8:950-957.
64. Ma, C.S., G.Y. Chew, N. Simpson, A. Priyadarshi, M. Wong, B. Grimbacher, D.A. Fulcher, S.G. Tangye, and M.C. Cook. 2008. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205:1551-1557.
65. de Beaucoudrey, L., A. Puel, O. Filipe-Santos, A. Cobat, P. Ghandil, M. Chrabieh, J. Feinberg, H. von Bernuth, A. Samarina, L. Janniere, et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205:1543-1550.
66. Eyerich, K., S. Foerster, S. Rombold, H.P. Seidl, H. Behrendt, H. Hofmann, J. Ring, and C. Traidl-Hoffmann. 2008. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 128:2640-2645.
67. Liang, S.C., X.Y. Tan, D.P. Luxenberg, R. Karim, K. Dunussi- Joannopoulos, M. Collins, and L.A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203:2271-2279.
68. Gudlaugsson, O., S. Gillespie, K. Lee, J. Vande Berg, J. Hu, S. Messer, L. Herwaldt, M. Pfaller, and D. Diekema. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect. Dis. 37:1172-1177.
69. Filler, S.G., M.R. Yeaman, and D.C. Sheppard. 2005. Tumor necrosis factor inhibition and invasive fungal infections. Clin. Infect. Dis. 41(Suppl 3):S208-S212.
70. Cecchinato, V., C. Trindale, A. Laurence, J. Heraud, J. Brenchley, M. Ferrari, L. Zaffri, E. Tryniszewska, W. Tsai, M. Vaccari, et al. 2008. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 1:279-288.
71. Collison, L.W., C.J. Workman, T.T. Kuo, K. Boyd, Y. Wang, K.M. Vignali, R. Cross, D. Sehy, R.S. Blumberg, and D.A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature. 450:566-569.
72. Rickel, E.A., L.A. Siegel, B.R. Yoon, J.B. Rottman, D.G. Kugler, D.A. Swart, P.M. Anders, J.E. Tocker, M.R. Comeau, and A.L. Budelsky. 2008. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 181:4299-4310.
73. Kikly, K., L. Liu, S. Na, and J.D. Sedgwick. 2006. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. 18:670-675.
74. Strangfeld, A., and J. Listing. 2006. Infection and musculoskeletal conditions: bacterial and opportunistic infections during anti-TNF therapy. Best Pract. Res. Clin. Rheumatol. 20:1181-1195.
75. Marino, M.W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. J ungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA. 94:8093-8098.
76. Zheng, Y., D.M. Danilenko, P. Valdez, I. Kasman, J. Eastham- Anderson, J. Wu, and W. Ouyang. 2007. I nterleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445:648-651.
77. Shen, F., M.J. Ruddy, P. Plamondon, and S.L. Gaffen. 2005. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J. Leukoc. Biol. 77:388-399.